The Founder, Chairman, and Chief Executive Officer (CEO) of Concordance, Danny Ludeman, shared a personal health update with the Board of Directors on May 14, 2024. He has been diagnosed with early-stage pancreatic cancer and has begun a treatment plan in coordination with his medical team at Johns Hopkins. To prioritize his health at this time, Danny will transition to the role of Executive Chairman effective immediately, and current President and Chief Operating Officer (COO), Michelle Smith, will assume the role of CEO. The transition follows a decade of collaboration between the Danny and Michelle and is simply an acceleration of their original succession plan. Danny and his medical team are optimistic about his prognosis and expresses full confidence in Michelle’s leadership to continue the Concordance mission. For media inquiries, please contact Jordan.Lubowitz@ogilvy.com.
Recent Stories
Concordance Begins National Search For New CEO
Susan Stith Named Interim CEO.
Concordance Begins Operations in South Carolina.
Dave Steward Named Chairman of Concordance
Dave Steward, Founder and Chairman of World Wide Technology and Chair of Concordance’s First Chance campaign, has graciously agreed to assume the role of Chairman of Concordance’s Board of Directors […]
Concordance Announces CEO Transition
The Founder, Chairman, and Chief Executive Officer (CEO) of Concordance, Danny Ludeman, shared a personal health update with the Board of Directors on May 14, 2024. He has been diagnosed […]